MCL-1 expression in B-cell non-Hodgkin's lymphomas

Human Pathology

Volumn 35, Issue 9, 2004, Pages 1095-1100

  Cho Vega, Jeong Hee ^a   Rassidakis, George Z ^a   Admirand, Joan H ^a   Oyarzo, Mauricio ^a   Ramalingam, Preetha ^a   Paraguya, Aris ^a   McDonnell, Timothy J ^a   Amin, Hesham M ^a   Medeiros, L Jeffrey ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

B cell; BCL 2 homology 3; BH3; immunohistochemistry; MALT; MCL 1; MCL 1 protein; mucosa associated lymphoma tissue; myeloid cell leukemia 1 protein; non Hodgkin's lymphoma

Indexed keywords

ISOPROTEIN; PROTEIN MCL 1;

ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; MULTIPLE MYELOMA; NEOPLASM PROTEINS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL;

EID: 4444365042     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.04.018     Document Type: Article

References (35)

1. Kozopas K.M., Yang T., Buchan H.L., et al. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci U S A. 90:1993;3516-3520
2. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776
3. Ohta K., Iwai K., Kasahara Y., et al. Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-X and Mcl-1, in human peripheral blood and lymphoid tissues. Int Immunol. 7:1995;1817-1825
4. Moulding D.A., Quayle J.A., Hart C.A., et al. Mcl-1 expression in human neutrophils Regulation by cytokines and correlation with cell survival. Blood. 92:1998;2495-2502
5. Craig R.W. MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia. 16:2002;444-454
6. Agarwal B., Naresh K.N. Bcl-2 family of proteins in indolent B-cell non-Hodgkin's lymphoma Study of 116 cases. Am J Hematol. 70:2002;278-282
7. Zhang B., Potyagaylo V., Fenton R.G. IL-6-independent expression of Mcl-1 in human multiple myeloma. Oncogene. 22:2003;1848-1859
8. Bingle C.D., Craig R.W., Swales B.M., et al. Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death. J Biol Chem. 275:2000;22136-22146
9. Bae J., Leo C.P., Hsu S.Y., et al. MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. J Biol Chem. 275:2000;25255-25261
10. Zhou P., Qian L., Bieszczad C.K., et al. Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage. Blood. 92:1998;3226-3239
11. Zhou P., Levy N.B., Xie H., et al. MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood. 97:2001;3902-3909
12. Krajewski S., Bodrug S., Krajewska M., et al. Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol. 146:1995;1309-1319
13. Soini Y., Raunio H., Paakko P. High-grade malignant non-Hodgkin's lymphomas differ from low-grade lymphomas in the extent of apoptosis and their expression of bcl-2, mcl-1, bax and p53. Tumour Biol. 19:1998;176-185
14. Schlaifer D., Krajewski S., Galoin S., et al. Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection. Am J Pathol. 149:1996;177-185
15. Rassidakis G.Z., Jones D., Lai R., et al. BCL-2 family proteins in peripheral T-cell lymphomas Correlation with tumour apoptosis and proliferation. J Pathol. 200:2003;240-248
16. Khoury J.D., Medeiros L.J., Rassidakis G.Z., et al. Expression of the anti-apoptotic protein Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, high proliferative rate and p53 overexpression. J Pathol. 199:2003;90-97
17. Vassallo J., Metze K., Traina F., et al. The prognostic relevance of apoptosis-related proteins in classical Hodgkin's lymphomas. Leuk Lymphoma. 44:2003;483-488
18. Grogan T.M., Miller T.P., Fisher R.I. A Southwest Oncology Group perspective on the Revised European-American Lymphoma classification. Hematol Oncol Clin North Am. 11:1997;819-846
19. Volpe G., Vitolo U., Carbone A., et al. Molecular heterogeneity of B-lineage diffuse large cell lymphoma. Genes Chromosomes Cancer. 16:1996;21-30
20. Lomo J., Smeland E.B., Krajewski S., et al. Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res. 56:1996;40-43
21. Jaffe E.S., Harris N.L., Stein H., et al. World Health Organization Classification of TumoursPathology and genetics of tumours of haematopoietic and lymphoid tissues. 2001;IARC Press, Lyon, France
22. Rassidakis G.Z., Lai R., McDonnell T.J., et al. Overexpression of mcl-1 in anaplastic large cell lymphoma cell lines and tumors. Am J Pathol. 160:2002;2309-2310
23. Domina A.M., Smith J.H., Craig R.W. Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition. J Biol Chem. 275:2000;21688-21694
24. Pagnano K.B., Silva M.D., Vassallo J., et al. Apoptosis-regulating proteins and prognosis in diffuse large B cell non-Hodgkin's lymphomas. Acta Haematol. 107:2002;29-34
25. Zha J., Harada H., Yang E., et al. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 87:1996;619-628
26. Puthalakath H., Huang D.C., O'Reilly L.A., et al. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell. 3:1999;287-296
27. Li H., Zhu H., Xu C.J., et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501
28. Bastion Y., Sebban C., Berger F., et al. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol. 15:1997;1587-1594
29. Boonstra R., Bosga-Bouwer A., Mastik M., et al. Identification of chromosomal copy number changes associated with transformation of follicular lymphoma to diffuse large B-cell lymphoma. Hum Pathol. 34:2003;915-923
30. Kitada S., Andersen J., Akar S., et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia Correlations with in vitro and in vivo chemoresponses. Blood. 91:1998;3379-3389
31. Bannerji R., Kitada S., Flinn I.W., et al. Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia Relationship to in vivo rituximab resistance. J Clin Oncol. 21:2003;1466-1471
32. Leitch D., Barrans S.L., Jack A.S., et al. Dysregulation of apoptosis in Waldenstrom's macroglobulinemia does not involve nuclear factor kappa B activation. Semin Oncol. 30:2003;161-164
33. Hallek M., Bergsagel P.L., Anderson K.C. Multiple myeloma Increasing evidence for a multistep transformation process. Blood. 91:1998;3-21
34. Zhang B., Gojo I., Fenton R.G. Myeloid cell factor-1 is a critical survival factor for multiple myeloma. Blood. 99:2002;1885-1893
35. Derenne S., Monia B., Dean N.M., et al. Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells. Blood. 100:2002;194-199